Table 2.
Effects of the patient care team for hypertension on office systolic blood pressure in subgroups
| Subgroups | Trials | Mean difference (mmHg) | Heterogeneity (%) | Test for overall effect | P-value for heterogeneity | ||
|---|---|---|---|---|---|---|---|
| N | Mean (95% CI) | I2 | P-value | Z | P-value | P-value | |
| Intervention | 0.46 | ||||||
| Pharmacist-led | 22 | −5.74 (−7.10, −4.38) | 74 | <0.001 | 8.27 | <0.001 | |
| Nurse-led | 16 | −5.79 (−7.69, −3.88) | 74 | <0.001 | 5.96 | <0.001 | |
| Physician-led | 6 | −4.07 (−7.31, −0.83) | 76 | <0.001 | 2.46 | <0.001 | |
| CHW-led | 6 | −8.02 (−16.10, 0.07) | 99 | <0.001 | 1.94 | 0.05 | |
| Others | 7 | −8.03 (−10.95, −5.10) | 42 | 0.11 | 5.37 | <0.001 | |
| Follow-up periods | 0.37 | ||||||
| ≤6 months | 33 | −6.15 (−7.20, −5.11) | 59 | <0.001 | 11.55 | <0.001 | |
| >6 to ≤12 months | 16 | −4.77 (−6.77, −2.77) | 84 | <0.001 | 4.68 | <0.001 | |
| >12 months | 8 | −8.51 (−15.55, −1.48) | 99 | <0.001 | 2.37 | 0.02 | |
| Mean age | 0.89 | ||||||
| <65 years | 47 | −6.27 (−7.85, −4.69) | 95 | <0.001 | 7.79 | <0.001 | |
| ≥65 years | 10 | −6.53 (−9.94, −3.11) | 81 | <0.001 | 3.75 | <0.001 | |
| Countries/regions | 0.59 | ||||||
| United States | 30 | −6.24 (−7.55, −4.93) | 68 | <0.001 | 9.32 | <0.001 | |
| China/Hong Kong | 10 | −7.36 (−14.08, −0.65) | 99 | <0.001 | 2.15 | 0.03 | |
| Other countries/regions | 17 | −5.34 (−6.72, −3.95) | 72 | <0.001 | 7.56 | <0.001 | |
CHW community health worker, CI confidence interval, HT hypertension, N number